116 related articles for article (PubMed ID: 10967275)
1. Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses.
Mehra MR; Uber PA; Prasad AK; Park MH; Scott RL; McFadden PM; Van Meter CH
J Heart Lung Transplant; 2000 Aug; 19(8):801-4. PubMed ID: 10967275
[TBL] [Abstract][Full Text] [Related]
2. Transmyocardial laser revascularization in allograft coronary artery disease.
Frazier OH; Kadipasaoglu KA; Radovancevic B; Cihan HB; March RJ; Mirhoseini M; Cooley DA
Ann Thorac Surg; 1998 Apr; 65(4):1138-41. PubMed ID: 9564946
[TBL] [Abstract][Full Text] [Related]
3. Management of cardiac allograft vasculopathy by transmyocardial laser revascularization.
Malik FS; Mehra MR; Ventura HO; Smart FW; Stapleton DD; Ochsner JL
Am J Cardiol; 1997 Jul; 80(2):224-5. PubMed ID: 9230169
[TBL] [Abstract][Full Text] [Related]
4. Transmyocardial revascularization for cardiac transplantation allograft vasculopathy.
McFadden PM; Robbins RJ; Ochsner JL; Van Meter CH; Majorie S
J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1385-8. PubMed ID: 9628685
[No Abstract] [Full Text] [Related]
5. Cardiac allograft vasculopathy: the potential role for transmyocardial laser revascularization.
March RJ; Guynn T
J Heart Lung Transplant; 1995; 14(6 Pt 2):S242-6. PubMed ID: 8719494
[No Abstract] [Full Text] [Related]
6. Survival after transmyocardial laser revascularization in relation to nonlasered perfused myocardial zones.
Kraatz EG; Misfeld M; Jungbluth B; Sievers HH
Ann Thorac Surg; 2001 Feb; 71(2):532-6. PubMed ID: 11235701
[TBL] [Abstract][Full Text] [Related]
7. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up [ssee comments].
Nägele H; Stubbe HM; Nienaber C; Rödiger W
Eur Heart J; 1998 Oct; 19(10):1525-30. PubMed ID: 9820991
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy.
Simpson L; Lee EK; Hott BJ; Vega DJ; Book WM
J Heart Lung Transplant; 2005 Sep; 24(9):1211-7. PubMed ID: 16143235
[TBL] [Abstract][Full Text] [Related]
9. [Transmyocardial laser revascularization: a past or future treatment method? (review of the literature)].
Kinduris S
Medicina (Kaunas); 2002; 38(6):585-91. PubMed ID: 12474664
[TBL] [Abstract][Full Text] [Related]
10. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
[TBL] [Abstract][Full Text] [Related]
11. New developments in the diagnosis and management of cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
[TBL] [Abstract][Full Text] [Related]
12. Reoperative transmyocardial laser revascularization for late recurrent angina.
Lee R; Fischer KC; Moon MR
Ann Thorac Surg; 2002 Feb; 73(2):650-2. PubMed ID: 11845894
[TBL] [Abstract][Full Text] [Related]
13. Impact of plaque burden on compensatory enlargement of coronary arteries in cardiac allograft vasculopathy. Working Group on Cardiac Allograft Vasculopathy.
Pethig K; Heublein B; Wahlers T
Am J Cardiol; 1997 Jan; 79(1):89-92. PubMed ID: 9024747
[TBL] [Abstract][Full Text] [Related]
14. Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency.
Cooley DA; Frazier OH; Kadipasaoglu KA; Pehlivanoglu S; Shannon RL; Angelini P
Tex Heart Inst J; 1994; 21(3):220-4. PubMed ID: 8000270
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic improvement after transmyocardial laser revascularization: how long does it last?
De Carlo M; Milano AD; Pratali S; Levantino M; Mariotti R; Bortolotti U
Ann Thorac Surg; 2000 Sep; 70(3):1130-3. PubMed ID: 11016395
[TBL] [Abstract][Full Text] [Related]
16. [Experimental, morphological and clinical aspects of transmyocardial laser revascularization].
Kozel' AI; Giniatullin RU; Evdokimov SV; Golovneva ES; Astakhova LV
Khirurgiia (Mosk); 2000; (11):8-10. PubMed ID: 11220925
[TBL] [Abstract][Full Text] [Related]
17. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
Mehra MR; Ventura HO; Smart FW; Stapleton DD
J Heart Lung Transplant; 1995; 14(6 Pt 2):S246-9. PubMed ID: 8719495
[No Abstract] [Full Text] [Related]
18. Transmyocardial laser revascularization: early results and 1-year follow-up.
Agarwal R; Ajit M; Kurian VM; Rajan S; Arumugam SB; Cherian KM
Ann Thorac Surg; 1999 Feb; 67(2):432-6. PubMed ID: 10197665
[TBL] [Abstract][Full Text] [Related]
19. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium.
Hughes GC; Biswas SS; Yin B; Baklanov DV; Annex BH; Coleman RE; DeGrado TR; Landolfo CK; Landolfo KP; Lowe JE
J Am Coll Cardiol; 2002 Apr; 39(7):1220-8. PubMed ID: 11923050
[TBL] [Abstract][Full Text] [Related]
20. Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy.
Haddad F; Perez M; Fleischmann D; Valantine H; Hunt SA
J Heart Lung Transplant; 2006 Nov; 25(11):1367-70. PubMed ID: 17097503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
